Difference between revisions of "Citalopram-escitalopram"
From Psychiatrienet
| (3 intermediate revisions by 2 users not shown) | |||
| Line 4: | Line 4: | ||
| start = | | start = | ||
| stop = | | stop = | ||
| − | * | + | * '''Day 1:''' stop administration abruptly. |
| start = | | start = | ||
* No wash-out period is applied. | * No wash-out period is applied. | ||
| − | * | + | * '''Day 2:''' start escitalopram in half the dosage of citalopram. |
| info = | | info = | ||
| − | + | * The enantiomers of the racemic mixture citalopram and es-citalopram have qualitatively a quite similar pharmacological effect, therefore the switch is generally not advised | |
| − | |||
| − | * The enantiomers the racemic mixture citalopram and es-citalopram have qualitatively a quite similar pharmacological effect | ||
}} | }} | ||
Latest revision as of 15:48, 24 February 2023
| ||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||
Switch medication from Citalopram to Escitalopram.[1] [2]
Stop Citalopram - Day 1: stop administration abruptly.
Start Escitalopram- No wash-out period is applied.
- Day 2: start escitalopram in half the dosage of citalopram.
More information- The enantiomers of the racemic mixture citalopram and es-citalopram have qualitatively a quite similar pharmacological effect, therefore the switch is generally not advised
- ↑ Switches are based on literature references on this page and expert opinions of the authors. The authors have used pharmacokinetic and receptor affinity properties to determine the switch schedules
- ↑ Stahl, S. M. (2013). Stahl's essential psychopharmacology: Neuroscientific basis and practical applications (4th ed.). Cambridge University Press.
The editors of psychiatrienet.nl take the greatest care to provide up-to-date and accurate information on this site. Nevertheless, mistakes and omissions cannot be entirely excluded. No rights devolve from the information provided. The editors and other providers of information to this site accept no responsibility for the content of this site or for the information provided therein; neither do they accept responsibility for possible damages which may derive from the use of the information on this site or from the linked sites. The editorial board accepts no responsibility for the content of the (linked) sites, for access to them, or for the products and services on these sites, nor for the occurrence of errors, viruses, and/or disruptions in service.
